CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 2,000 shares at an average $16.12 ($32,236)
- 4 Open-market buy Director bought 3,550 shares at an average $16.12 ($57,209)
- 4 Open-market buy Director bought 3,550 shares at an average $15.88 ($56,358)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 30 of 62 · 1,224 filings